Two New Considerations for Improving the Diagnosis of α1-Antitrypsin Deficiency-Associated Liver Disease
- 30 January 2015
- journal article
- editorial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (6) , 1511-1513
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Fluphenazine Reduces Proteotoxicity in C. elegans and Mammalian Models of Alpha-1-Antitrypsin DeficiencyPLOS ONE, 2014
- Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin–related liver disease in miceJournal of Clinical Investigation, 2013
- The Electrophoretic α1-Globulin Pattern of Serum in α1-Antitrypsin DeficiencyCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2013
- Regulation of lipid stores and metabolism by lipophagyCell Death & Differentiation, 2012
- Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cellsNature, 2011
- An Autophagy-Enhancing Drug Promotes Degradation of Mutant α 1 -Antitrypsin Z and Reduces Hepatic FibrosisScience, 2010
- The liver in 30-year-old individuals with alpha1-antitrypsin deficiencyScandinavian Journal of Gastroenterology, 2009
- Does the Heterozygous State of Alpha‐1 Antitrypsin Deficiency Have a Role in Chronic Liver Diseases? Interim Results of a Large Case‐Control StudyJournal of Pediatric Gastroenterology and Nutrition, 2006
- Risk of Cirrhosis and Primary Liver Cancer in Alpha1-Antitrypsin DeficiencyNew England Journal of Medicine, 1986
- The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin DeficiencyScandinavian Journal of Clinical and Laboratory Investigation, 1963